Dow Jones Rises as Amgen and NVIDIA Drive Market Momentum

The Dow Jones Industrial Average (DJIA) surged on Wednesday morning, gaining 148 points (+0.3%), fueled by strong performances from Amgen Inc. (NASDAQ: AMGN) and NVIDIA Corp. (NASDAQ: NVDA). The rally underscores investor optimism in biotech and semiconductor stocks, driving momentum in the broader market.

Amgen (AMGN) Leads Biotech Surge with a 5.48% Gain

Shares of Amgen Inc. soared +5.48%, making it one of the top performers in the Dow. The biopharmaceutical giant’s strong movement comes amid positive sentiment in the healthcare sector, with investors betting on biotech innovation and potential regulatory approvals. Amgen’s pipeline advancements and strategic acquisitions continue to bolster investor confidence, positioning the company for long-term growth in precision medicine and immunotherapy.

NVIDIA (NVDA) Climbs 4.20% as AI and Chip Demand Soar

NVIDIA Corp. (NVDA) jumped 4.20%, reinforcing its dominance in the AI and semiconductor industry. The company remains a market leader in AI-driven computing, with continued demand for GPUs in data centers, cloud computing, and gaming. As the global race for AI supremacy heats up, investors are doubling down on NVIDIA’s potential to capitalize on the next wave of technological advancements.

Dow Jones Rally: Market Sentiment Remains Bullish

With Amgen and NVIDIA leading the charge, the Dow Jones remains in positive territory, reflecting broader investor confidence in healthcare and technology stocks. As earnings reports and economic indicators continue to shape the market landscape, traders are keeping a close eye on sector trends and macroeconomic data.

With biotech innovation and AI-driven growth fueling the markets, Amgen and NVIDIA remain key stocks to watch as Wall Street navigates the evolving investment landscape.